Workup and Treatment for 85-Year-Old with Daytime Urge Incontinence and Lack of Bladder Awareness
Start with bladder training as first-line treatment for this patient's urgency urinary incontinence, and if unsuccessful after an adequate trial, add antimuscarinic pharmacotherapy, selecting agents based on tolerability and adverse effect profile—specifically choosing tolterodine or darifenacin over oxybutynin due to lower discontinuation rates in elderly patients 1.
Critical Clinical Context
The lack of awareness of needing to use the bathroom is particularly concerning in an 85-year-old and suggests impaired bladder sensation or possible cognitive impairment, which fundamentally changes the approach. This is not typical urgency incontinence where patients feel a sudden compelling urge—this patient has urge incontinence without the awareness component, which may indicate:
- Functional or cognitive impairment affecting bladder awareness
- Detrusor overactivity with impaired sensory function
- Early dementia or delirium affecting continence pathways
Essential Workup Components
History Focus
- Cognitive assessment: Screen for delirium, dementia, or acute confusional states that impair bladder awareness 1
- Medication review: Identify drugs causing or worsening incontinence (diuretics, sedatives, anticholinergics, alpha-blockers) 1
- Reversible causes: Urinary tract infection, metabolic disorders (hyperglycemia, hypercalcemia), excess fluid intake, constipation 1
- Voiding diary: 3-day record documenting timing, volume, and circumstances of incontinence episodes 1, 2
- Functional status: Mobility, ability to reach toilet independently, manual dexterity for clothing 3
Physical Examination
- Abdominal examination: Palpable bladder, masses, surgical scars
- Pelvic examination: Atrophic vaginitis, pelvic organ prolapse, pelvic mass
- Rectal examination: Fecal impaction, prostate assessment if male, rectal tone
- Neurological screening: Perineal sensation, bulbocavernosus reflex if neurogenic suspected 4
Laboratory and Diagnostic Tests
- Urinalysis: Rule out infection, hematuria, glucosuria 4, 2
- Post-void residual (PVR) measurement: Via bladder ultrasound to exclude overflow incontinence (PVR >200 mL warrants further evaluation) 4, 2
- Uroflowmetry: If available and patient can cooperate, assess voiding pattern 4
When to Consider Advanced Testing
Do NOT routinely perform urodynamics or cystoscopy unless 5:
- Hematuria present
- Recurrent urinary tract infections
- Elevated post-void residual suggesting obstruction
- Prior anti-incontinence surgery
- Diagnostic uncertainty after basic evaluation
- Considering surgical intervention
Treatment Algorithm
Step 1: Address Reversible Causes First
- Treat urinary tract infection if present
- Optimize management of diabetes, heart failure, or other metabolic conditions
- Discontinue or adjust medications worsening incontinence
- Manage constipation aggressively 1
Step 2: Behavioral and Non-Pharmacologic Interventions (First-Line)
Bladder training is the cornerstone for urgency incontinence 1:
- Scheduled voiding every 2-3 hours initially
- Gradually extend intervals between voids by 15-30 minutes
- Teach urge suppression techniques
- Continue for at least 6-8 weeks before assessing efficacy
However, given the lack of bladder awareness, prompted voiding or timed voiding may be more appropriate 3:
- Caregiver-initiated toileting every 2-3 hours
- Does not require patient awareness or cooperation
- More realistic for cognitively impaired elderly
Fluid management 5:
- Limit fluids after 6 PM to reduce nighttime production
- Avoid caffeine and alcohol
- Maintain adequate daytime hydration (not excessive)
Weight loss if obese (BMI >30) 1
Step 3: Pharmacologic Therapy (Second-Line)
Only initiate if bladder training unsuccessful after adequate trial (6-8 weeks) 1.
Medication Selection Priority for 85-Year-Old:
First choice: Tolterodine or Darifenacin 1:
- These have discontinuation rates due to adverse effects similar to placebo
- Lower risk of cognitive impairment compared to oxybutynin
- Tolterodine: Start 2 mg twice daily or 4 mg extended-release once daily
- Darifenacin: Start 7.5 mg once daily
Avoid oxybutynin 1:
- Highest discontinuation rate (NNTH 16)
- More dry mouth, insomnia, dizziness
- Greater anticholinergic burden—critical concern in elderly with potential cognitive issues
Alternative: Mirabegron (beta-3 agonist) 1, 6:
- Does not worsen cognition
- Contraindicated in severe uncontrolled hypertension
- May be preferred if anticholinergic side effects are intolerable
- Start 25 mg once daily, can increase to 50 mg
Critical Anticholinergic Cautions in 85-Year-Olds:
All antimuscarinics carry risk of 1, 7:
- Dry mouth, constipation, blurred vision
- Cognitive impairment and confusion—especially problematic given baseline lack of bladder awareness
- Urinary retention—monitor post-void residual
- Falls risk due to dizziness
Monitor closely: Reassess symptoms, PVR, and cognitive status within 4-6 weeks of starting medication 1, 7.
Step 4: Incontinence Management Strategies
Regardless of treatment chosen, provide practical management 5:
- Absorbent pads or protective underwear
- Barrier creams to prevent skin breakdown
- Bedside commode or urinal if mobility limited
- Environmental modifications (clear path to bathroom, adequate lighting)
Special Considerations for This Patient
The "No Nocturnal Incontinence" Pattern
This suggests:
- Reduced nocturnal urine production (normal age-related change)
- Better bladder capacity at night when not distracted
- Possible daytime functional or cognitive factors contributing to incontinence
- Less likely to be pure detrusor overactivity (which typically causes nocturia)
The Lack of Awareness Component
This is NOT typical urgency incontinence and requires:
- Formal cognitive assessment before attributing to simple OAB
- Consideration of functional incontinence component
- Caregiver involvement in treatment plan
- Lower threshold for prompted/scheduled voiding rather than self-initiated bladder training
Common Pitfalls to Avoid
Starting antimuscarinics without attempting behavioral therapy first—violates evidence-based guidelines 1
Choosing oxybutynin in elderly patients—highest adverse effect burden and discontinuation rate 1
Ignoring cognitive impairment—may be primary driver of incontinence, not OAB 1
Failing to check post-void residual—could miss overflow incontinence masquerading as urgency 4, 2
Not involving caregivers—essential for success in patients with impaired awareness 3
Overlooking medication-induced incontinence—common and reversible 1